3-1-Methylpyrrolidin-2-Yl-Pyridine | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

3-1-Methylpyrrolidin-2-Yl-Pyridine
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

3-1-Methylpyrrolidin-2-Yl-Pyridine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 41 USDMF, 16 CEP/COS, 2 JDMF, 6 EU WC, 18 NDC API, 8 Listed Suppliers, $ API Reference Price

58 API Suppliers
41 USDMF
16 CEP/COS
2 JDMF
6 EU WC
18 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

119 Drugs in Development

119 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers, 102 FDA Orange Book, 66 Europe, 9 Australia, 22 South Africa, 16 Listed Dossiers

215 FDF Dossiers
102 FDA Orange Book
66 Europe
9 Australia
22 South Africa
16 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GUM, CHEWING;BUCCAL - EQ 2MG BASE, GUM, CHEWING;BUCCAL - EQ 4MG BASE, FILM, EXTENDED RELEASE;TRANSDERMAL - 14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 21MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 7MG/24HR, INHALANT;ORAL - 4MG/CARTRIDGE, TROCHE/LOZENGE;ORAL - EQ 2MG BASE, TROCHE/LOZENGE;ORAL - EQ 4MG BASE

GUM, CHEWING;BUCCAL - EQ 2MG BASE
GUM, CHEWING;BUCCAL - EQ 4MG BASE
FILM, EXTENDED RELEASE;TRANSDERMAL - 14MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 21MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 7MG/24HR
INHALANT;ORAL - 4MG/CARTRIDGE
TROCHE/LOZENGE;ORAL - EQ 2MG BASE
TROCHE/LOZENGE;ORAL - EQ 4MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 10 Rochem International Inc, 22 SPI Pharma, 20 DKSH, 2 Pharm-RX Chemical, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 15 Actylis, 2 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 5 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 10 Corel Pharma Chem, 4 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 11 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 5 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 33 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Sigachi Industries, 1 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Vasa Pharmachem, 1 Vertellus, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

64 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 40 Taste Masking, 32 Thickeners and Stabilizers, 25 Parenteral, 23 Chewable & Orodispersible Aids, 22 Direct Compression, 20 Solubilizers, 20 Film Formers & Plasticizers, 17 Topical, 17 Controlled & Modified Release, 11 Disintegrants & Superdisintegrants, 11 Lubricants & Glidants, 10 Emulsifying Agents, 9 Empty Capsules, 9 Granulation, 9 Rheology Modifiers, 7 Co-Processed Excipients, 7 API Stability Enhancers, 6 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

64 Fillers, Diluents & Binders
47 Coating Systems & Additives
40 Taste Masking
32 Thickeners and Stabilizers
25 Parenteral
23 Chewable & Orodispersible Aids
22 Direct Compression
20 Solubilizers
20 Film Formers & Plasticizers
17 Topical
17 Controlled & Modified Release
11 Disintegrants & Superdisintegrants
11 Lubricants & Glidants
10 Emulsifying Agents
9 Empty Capsules
9 Granulation
9 Rheology Modifiers
7 Co-Processed Excipients
7 API Stability Enhancers
6 Surfactant & Foaming Agents
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 667 News #PharmaBuzz

2 Data Compilation #PharmaFlow
667 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 22 Regulatory FDF Prices

2 US Medicaid Prescriptions
22 Regulatory FDF Prices

MARKET PLACE

13 APIs

13 APIs

PATENTS & EXCLUSIVITIES

6 US Patents, 3 Health Canada Patents

6 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM

4 EDQM

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ API Ref.Price (USD/KG) : 109 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 2Borden Ladner Gervais LLP

02 1McNeil Consumer Healthcare, division of Johnson & Johnson Inc.

filter Patent Reset all filters

3 All

01 21333051

02 12172402

filter Product Reset all filters

3 All

01 3Nicotine

filter Dosage Reset all filters

3 All

01 2Patch

02 1Transdermal patch

filter Exp Date Reset all filters

3 All

01 22011-11-15

02 12014-09-16

Product Main Page

01

McNeil Consumer Healthcare, division of Jo...

Nicotine

Peptide Process CMC

Not Confirmed

McNeil Consumer Healthcare, divisio...

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-09-16

Date Granted : 2005-08-23

Brand Name : NICORETTE INVISIPATCH

Patent Number : 2172402

Filing Date : 1994-09-16

Strength per Unit : 25 mg / 6 hour

Dosage Form : Transdermal patch

Human Or VET : Human

Route of Administration : Topically allied patch

Patent Expiration Date : 2014-09-16

Date Granted : 2005-08-23

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

Borden Ladner Gervais LLP

Nicotine

Peptide Process CMC

Not Confirmed

Borden Ladner Gervais LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-15

Date Granted : 1994-11-15

Brand Name : PROSTEP TRANSDERMAL SYSTEM

Patent Number : 1333051

Filing Date : 1988-04-29

Strength per Unit : 11mg

Dosage Form : Patch

Human Or VET : Human

Route of Administration : Transdermal

Patent Expiration Date : 2011-11-15

Date Granted : 1994-11-15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Borden Ladner Gervais LLP

Nicotine

Peptide Process CMC

Not Confirmed

Borden Ladner Gervais LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-15

Date Granted : 1994-11-15

Brand Name : PROSTEP TRANSDERMAL SYSTEM

Patent Number : 1333051

Filing Date : 1988-04-29

Strength per Unit : 22mg

Dosage Form : Patch

Human Or VET : Human

Route of Administration : Transdermal

Patent Expiration Date : 2011-11-15

Date Granted : 1994-11-15

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!